Details
Stereochemistry | ACHIRAL |
Molecular Formula | C29H29F6N3O2 |
Molecular Weight | 565.5499 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C(=O)C(C)(C)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)C2=CN=C(C=C2C3=CC=CC=C3C)N4CCOCC4
InChI
InChIKey=ZGNPLCMMVKCTHM-UHFFFAOYSA-N
InChI=1S/C29H29F6N3O2/c1-18-7-5-6-8-22(18)23-16-25(38-9-11-40-12-10-38)36-17-24(23)37(4)26(39)27(2,3)19-13-20(28(30,31)32)15-21(14-19)29(33,34)35/h5-8,13-17H,9-12H2,1-4H3
Molecular Formula | C29H29F6N3O2 |
Molecular Weight | 565.5499 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Befetupitant (Ro67-5930) is a high-affinity, competitive, tachykinin 1 receptor (NK1R) antagonist that was initially invented by Hoffmann-La Roche as a potential antiemetic drug. These studies were discontinued, because of the clinical trials with the more suitable drug, netupitant. Befetupitant was also investigated for topical application to reduced corneal neovascularization in the alkali burn model. However, the drug was toxic and was not tested in the suture model.
CNS Activity
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL249 Sources: https://www.ncbi.nlm.nih.gov/pubmed/25228541 |
1.0 nM [Ki] |
Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:59:01 GMT 2025
by
admin
on
Mon Mar 31 17:59:01 GMT 2025
|
Record UNII |
RSH7NDI7MI
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C265
Created by
admin on Mon Mar 31 17:59:01 GMT 2025 , Edited by admin on Mon Mar 31 17:59:01 GMT 2025
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C508855
Created by
admin on Mon Mar 31 17:59:01 GMT 2025 , Edited by admin on Mon Mar 31 17:59:01 GMT 2025
|
PRIMARY | |||
|
C78006
Created by
admin on Mon Mar 31 17:59:01 GMT 2025 , Edited by admin on Mon Mar 31 17:59:01 GMT 2025
|
PRIMARY | |||
|
300000034096
Created by
admin on Mon Mar 31 17:59:01 GMT 2025 , Edited by admin on Mon Mar 31 17:59:01 GMT 2025
|
PRIMARY | |||
|
RSH7NDI7MI
Created by
admin on Mon Mar 31 17:59:01 GMT 2025 , Edited by admin on Mon Mar 31 17:59:01 GMT 2025
|
PRIMARY | |||
|
DTXSID90183270
Created by
admin on Mon Mar 31 17:59:01 GMT 2025 , Edited by admin on Mon Mar 31 17:59:01 GMT 2025
|
PRIMARY | |||
|
290296-68-3
Created by
admin on Mon Mar 31 17:59:01 GMT 2025 , Edited by admin on Mon Mar 31 17:59:01 GMT 2025
|
PRIMARY | |||
|
8392
Created by
admin on Mon Mar 31 17:59:01 GMT 2025 , Edited by admin on Mon Mar 31 17:59:01 GMT 2025
|
PRIMARY | |||
|
Befetupitant
Created by
admin on Mon Mar 31 17:59:01 GMT 2025 , Edited by admin on Mon Mar 31 17:59:01 GMT 2025
|
PRIMARY | |||
|
6450815
Created by
admin on Mon Mar 31 17:59:01 GMT 2025 , Edited by admin on Mon Mar 31 17:59:01 GMT 2025
|
PRIMARY | |||
|
RR-92
Created by
admin on Mon Mar 31 17:59:01 GMT 2025 , Edited by admin on Mon Mar 31 17:59:01 GMT 2025
|
PRIMARY | |||
|
CHEMBL204694
Created by
admin on Mon Mar 31 17:59:01 GMT 2025 , Edited by admin on Mon Mar 31 17:59:01 GMT 2025
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|